NCT02556281View on ClinicalTrials.gov

Prognostic Value of Circulating Tumoral Free DNA Versus Circulating Tumoral Cells in Patients With Colorectal Cancer Stage II-III

NACompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

October 15, 2012

Primary Completion Date

June 3, 2019

Study Completion Date

June 3, 2019

Conditions
Colorectal Neoplasms
Interventions
BIOLOGICAL

Blood sampling

Blood sampling is done for patient with colorectal cancer

Trial Locations (1)

76031

Rouen University Hospital, Rouen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT02556281 - Prognostic Value of Circulating Tumoral Free DNA Versus Circulating Tumoral Cells in Patients With Colorectal Cancer Stage II-III | Biotech Hunter | Biotech Hunter